Accéder au contenu
Merck

Greater muscle protein synthesis and mitochondrial biogenesis in males compared with females during sprint interval training.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology (2014-03-07)
Rebecca L Scalzo, Garrett L Peltonen, Scott E Binns, Mahalakshmi Shankaran, Gregory R Giordano, Dylan A Hartley, Anna L Klochak, Mark C Lonac, Hunter L R Paris, Steve E Szallar, Lacey M Wood, Frederick F Peelor, William E Holmes, Marc K Hellerstein, Christopher Bell, Karyn L Hamilton, Benjamin F Miller
RÉSUMÉ

Improved endurance exercise performance in adult humans after sprint interval training (SIT) has been attributed to mitochondrial biogenesis. However, muscle protein synthesis (MPS) and mitochondrial biogenesis during SIT have not been measured, nor have sex-specific differences. We hypothesized that males and females would have similar rates of MPS, mitochondrial biogenesis, and synthesis of individual proteins during SIT. Deuterium oxide (D2O) was orally administered to 21 adults [11 male, 10 female; mean age, 23±1 yr; body mass index (BMI), 22.8±0.6 kg/m(2); mean± SE] for 4 wk, to measure protein synthesis rates while completing 9 sessions of 4-8 bouts of 30 s duration on a cycle ergometer separated by 4 min of active recovery. Samples of the vastus lateralis were taken before and 48 h after SIT. SIT increased maximum oxygen uptake (VO(2max), males 43.4±2.1-44.0±2.3; females 39.5±0.9-42.5±1.3 ml/kg/min; P=0.002). MPS was greater in the males than in the females in the mixed (~150%; P < 0.001), cytosolic (~135%; P=0.038), and mitochondrial (~135%; P=0.056) fractions. The corresponding ontological clusters of individual proteins were significantly greater in the males than in the females (all P<0.00001). For the first time, we document greater MPS and mitochondrial biogenesis during SIT in males than in females and describe the synthetic response of individual proteins in humans during exercise training.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Sulfate de sodium, ACS reagent, ≥99.0%, anhydrous, granular
Sigma-Aldrich
Sulfate de sodium, ACS reagent, ≥99.0%, anhydrous, powder
Sigma-Aldrich
Iodoacétamide, Single use vial of 56 mg
Sigma-Aldrich
Iodoacétamide, BioUltra
Sigma-Aldrich
BIS-TRIS, ≥98.0% (titration)
Sigma-Aldrich
Iodoacétamide, ≥99% (NMR), crystalline
Sigma-Aldrich
Sulfate de sodium, ReagentPlus®, ≥99.0%
SAFC
BIS-TRIS
Sigma-Aldrich
Sulfate de sodium, puriss., meets analytical specification of Ph. Eur., BP, USP, anhydrous, 99.0-100.5% (calc. to the dried substance)
Sigma-Aldrich
Sulfate de sodium, anhydrous, free-flowing, Redi-Dri, ACS reagent, ≥99%
Sigma-Aldrich
BIS-TRIS, BioXtra, ≥98.0% (titration)
Sigma-Aldrich
BIS-TRIS, BioUltra, ≥99.0% (NT)
Sigma-Aldrich
BIS-TRIS, BioPerformance Certified, suitable for cell culture, suitable for insect cell culture, ≥98.0%
Sigma-Aldrich
Sulfate de sodium, anhydrous, free-flowing, Redi-Dri, ReagentPlus®, ≥99%
SAFC
Iodoacétamide
Sigma-Aldrich
Sulfate de sodium, BioUltra, anhydrous, ≥99.0% (T)
Sigma-Aldrich
Sulfate de sodium, ≥99.99% trace metals basis
Sigma-Aldrich
Sulfate de sodium, BioXtra, ≥99.0%
SAFC
BIS-TRIS
Sigma-Aldrich
Sulfate de sodium, ≥99.0%, suitable for plant cell culture
Sigma-Aldrich
Sulfate de sodium, tested according to Ph. Eur., anhydrous